NONOF vs AZNCF: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A/S and AstraZeneca PLC in 2026
NONOF
Novo Nordisk A/S
$45.25
AZNCF
AstraZeneca PLC
—
Key Metrics Comparison
| Metric | NONOF | AZNCF | Winner |
|---|---|---|---|
| Market Cap | $317.17B | $290.60B | NONOF |
| P/E Ratio | 18.73 | 31.09 | NONOF |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze NONOF
Full quant analysis
Analyze AZNCF
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NONOF or AZNCF a better investment?
Comparing NONOF and AZNCF: Novo Nordisk A/S has a market cap of $317.17B while AstraZeneca PLC has $290.60B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NONOF and AZNCF?
NONOF (Novo Nordisk A/S) and AZNCF (AstraZeneca PLC) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NONOF or AZNCF?
Based on P/E ratios, NONOF trades at a lower multiple (18.7x vs 31.1x).
Which is growing faster: NONOF or AZNCF?
Both NONOF and AZNCF show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: NONOF or AZNCF?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: NONOF or AZNCF?
Novo Nordisk A/S (NONOF) is larger with a market cap of $317.17B compared to $290.60B for AZNCF.
Should I buy NONOF or AZNCF in 2026?
Both NONOF and AZNCF have investment merit. NONOF trades at $45.25 while AZNCF trades at $N/A. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NONOF and AZNCF stock?
Key differences: Market Cap ($317.17B vs $290.60B), P/E Ratio (18.7x vs 31.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy NONOF or AZNCF in 2026?
The choice between NONOF and AZNCF depends on your investment goals. AZNCF shows higher revenue growth (0.0%). AZNCF has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between NONOF and AZNCF?
NONOF (Novo Nordisk A/S) has a market cap of $317.17B, while AZNCF (AstraZeneca PLC) has a market cap of $290.60B. NONOF is the larger company by market value.